How Investors Reacted Market participants viewed Monday’s filing delay as a sign that the company may have erred in buying Level 3, which many bulls initially argued set up CenturyLink for more growth than other peers in the wireline industry. CTL stock responded with a 6.3% decline on Monday to $12.15 per share. That loss […]
Read MoreA few months ago, I wrote about the merger between pharmacy kingpin CVS Health Corporation (CVS) and healthcare insurer Aetna Inc. I decided to try to determine if the deal, which closed shortly after I wrote about it, offered a compelling reason to buy the stock at its price at the time, which at the […]
Read MoreFirst Vanadium Corp. engages in the acquisition, exploration, and development of mineral properties in Canada and the United States. The company explores for copper, silver, zinc, and gold minerals. It holds a 100% interest in the West Jerome property located in Jerome, Arizona. It also holds interest in the Carlin Vanadium project, which comprises 72 […]
Read MoreShares of The Gap Inc. (GPS) on Friday experienced their biggest daily gain in months following the clothing retailer’s huge announcement regarding its corporate structure moving forward. The news overshadowed the firm’s mixed Q4 earnings report, which beat on the bottom line but slightly whiffed on the top line. The Gap – which owns its […]
Read MoreFuel Tech, Inc. provides boiler optimization, efficiency improvement, and air pollution reduction and control solutions to utility and industrial customers worldwide. It operates through Air Pollution Control Technology and FUEL CHEM Technology segments. The Air Pollution Control Technology segment offers technologies to reduce nitrogen oxide (NOx) emissions in flue gas from boilers, incinerators, furnaces, and […]
Read MoreFor the last week or so, I’ve been focusing a lot of attention and analysis on the Food Products industry in the Consumer Staples sector. A lot of the stocks in this industry have increased nicely since the beginning of the year, but remain well below their 52-week highs. That’s opened up a lot of […]
Read MoreImmutep Limited (ASX: IMM; NASDAQ: IMMP) (Immutep or the Company), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, today announced its participation in various upcoming industry conferences. The Company will be presenting updated clinical data from the Phase I TACTI-mel trial in metastatic melanoma for its lead product candidate eftilagimod alpha […]
Read MoreThe month of February is now in the bag, and investors have plenty of reasons to celebrate. Despite the Dow Jones Industrial Average closing slightly lower on Thursday for its third straight daily loss, the index still managed an 11.1% gain in February. That marks the best two-month beginning of a year since 1987 when […]
Read More